Jubilant Life Sciences has raised Rs 50 crore through Commercial Papers (CPs) on June 12, 2020. Date of maturity of the said Commercial Papers is September 9, 2020. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 150 crore.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.